Welcome to LookChem.com Sign In|Join Free
  • or
2-bromo-N-(3,4-dimethoxybenzyl)benzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

895680-72-5

Post Buying Request

895680-72-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

895680-72-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 895680-72-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,5,6,8 and 0 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 895680-72:
(8*8)+(7*9)+(6*5)+(5*6)+(4*8)+(3*0)+(2*7)+(1*2)=235
235 % 10 = 5
So 895680-72-5 is a valid CAS Registry Number.

895680-72-5Downstream Products

895680-72-5Relevant academic research and scientific papers

Discovery of potent cytotoxic ortho-aryl chalcones as new scaffold targeting tubulin and mitosis with affinity-based fluorescence

Zhu, Cuige,Zuo, Yinglin,Wang, Ruimin,Liang, Baoxia,Yue, Xin,Wen, Gesi,Shang, Nana,Huang, Lei,Chen, Yu,Du, Jun,Bu, Xianzhang

, p. 6364 - 6382 (2014)

A series of new ortho-aryl chalcones have been designed and synthesized. Many of these compounds were found to exhibit significant antiproliferation activity toward a panel of cancer cell lines. Selected compounds show potent cytotoxicity against several drug resistant cell lines including paclitaxel (Taxol) resistant human ovarian carcinoma cells, vincristine resistant human ileocecum carcinoma cells, and doxorubicin resistant human breast carcinoma cells. Further investigation revealed that active analogues could inhibit the microtubule polymerization by binding to colchicine site and thus induce multipolar mitosis, G2/M phase arrest, and apoptosis of cancer cells. Furthermore, affinity-based fluorescence enhancement was observed during the binding of active compounds with tubulin, which greatly facilitated the determination of tubulin binding site of the compounds. Finally, selected compound 26 was found to exhibit obvious in vivo antitumor activity in A549 tumor xenografts model. Our systematic studies implied a new scaffold targeting tubulin and mitosis for novel antitumor drug discovery.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 895680-72-5